Paragon Biosciences Qlarity Capital, Inc. — Form D
Paragon Biosciences Qlarity Capital, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-12. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-11-12
- Form: D
- Accession: 0001793485-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Minimum investment: $15.0M
- Investors: 1
- Date of first sale: 2019-10-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-353125
Issuer
- Name: Paragon Biosciences Qlarity Capital, Inc.
- CIK: 0001793485
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 330 N. WABASH AVE., STE. 3500, CHICAGO, IL, 60611
- Phone: 3128471322
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jeffrey S Aronin | Director | Chicago, IL |
| Antonio J Gracias | Director | Chicago, IL |
| Patrick J Morris | Director | Chicago, IL |
| Patrick J Morris | Executive Officer | Chicago, IL |
| Darien J Parhad | Executive Officer | Chicago, IL |
More